Birdwatch Note
2024-05-01 00:00:35 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Metrópoles engana ao afirmar que esta seria a primeira vez que a farmacêutica admite tal efeito raro. A trombose, que ocorre em 1 a cada 100mil vacinados, é um efeito colateral conhecido desde 2021, inclusive sendo citado nas bulas da vacina emitidas pela FIOCRUZ. Bulas: https://consultas.anvisa.gov.br/#/bulario/detalhe/2011889?nomeProduto=VACINA%20COVID-19%20(RECOMBINANTE) https://www.estadao.com.br/estadao-verifica/astrazeneca-admite-efeito-colateral-grave/
Written by 2530CFE90BC84C29F7EBAD6D9FC3E750B4A0A191F22915127FF90AE0AC45630B
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1785277927862505964
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1785459264536105112
- noteId - 1785459264536105112
- participantId -
- noteAuthorParticipantId - 2530CFE90BC84C29F7EBAD6D9FC3E750B4A0A191F22915127FF90AE0AC45630B Participant Details
- createdAtMillis - 1714521635552
- tweetId - 1785277927862505964
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Metrópoles engana ao afirmar que esta seria a primeira vez que a farmacêutica admite tal efeito raro. A trombose, que ocorre em 1 a cada 100mil vacinados, é um efeito colateral conhecido desde 2021, inclusive sendo citado nas bulas da vacina emitidas pela FIOCRUZ. Bulas: https://consultas.anvisa.gov.br/#/bulario/detalhe/2011889?nomeProduto=VACINA%20COVID-19%20(RECOMBINANTE) https://www.estadao.com.br/estadao-verifica/astrazeneca-admite-efeito-colateral-grave/
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2024-05-01 00:00:35 UTC (1714521635552) |
2024-05-01 11:06:11 UTC (1714561571387) |
CURRENTLY_RATED_HELPFUL | 2024-05-01 12:35:12 UTC (1714566912495) |
CURRENTLY_RATED_HELPFUL | 2024-05-01 11:06:11 UTC (1714561571387) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
| rated at | rated by | |
| 2024-05-01 08:30:40 -0500 | Rating Details | |
| 2024-05-01 06:56:50 -0500 | Rating Details | |
| 2024-05-01 05:31:30 -0500 | Rating Details | |
| 2024-05-01 04:44:02 -0500 | Rating Details | |
| 2024-05-01 04:03:36 -0500 | Rating Details | |
| 2024-04-30 23:56:18 -0500 | Rating Details | |
| 2024-04-30 23:21:25 -0500 | Rating Details | |
| 2024-04-30 23:11:17 -0500 | Rating Details | |
| 2024-04-30 23:08:54 -0500 | Rating Details | |
| 2024-04-30 22:24:54 -0500 | Rating Details | |
| 2024-04-30 21:24:21 -0500 | Rating Details | |
| 2024-04-30 21:16:44 -0500 | Rating Details | |
| 2024-04-30 21:04:25 -0500 | Rating Details | |
| 2024-04-30 20:46:51 -0500 | Rating Details | |
| 2024-04-30 20:45:35 -0500 | Rating Details | |
| 2024-05-01 13:47:46 -0500 | Rating Details | |
| 2024-05-01 10:53:38 -0500 | Rating Details | |
| 2024-05-01 07:49:20 -0500 | Rating Details | |
| 2024-05-01 07:45:28 -0500 | Rating Details | |
| 2024-05-01 07:11:41 -0500 | Rating Details | |
| 2024-05-01 05:48:39 -0500 | Rating Details | |
| 2024-05-01 01:24:08 -0500 | Rating Details | |
| 2024-04-30 23:20:31 -0500 | Rating Details | |
| 2024-04-30 23:06:27 -0500 | Rating Details | |
| 2024-04-30 22:29:47 -0500 | Rating Details | |
| 2024-04-30 22:13:15 -0500 | Rating Details | |
| 2024-04-30 21:38:01 -0500 | Rating Details | |
| 2024-04-30 21:35:37 -0500 | Rating Details | |
| 2024-04-30 20:39:40 -0500 | Rating Details | |
| 2024-04-30 20:13:40 -0500 | Rating Details | |
| 2024-04-30 19:11:56 -0500 | Rating Details | |
| 2024-05-03 04:57:33 -0500 | Rating Details | |
| 2024-05-03 04:12:19 -0500 | Rating Details | |
| 2024-05-01 19:59:31 -0500 | Rating Details | |
| 2024-05-01 19:51:59 -0500 | Rating Details | |
| 2024-05-01 14:53:16 -0500 | Rating Details | |
| 2024-05-01 11:11:35 -0500 | Rating Details | |
| 2024-05-01 08:44:45 -0500 | Rating Details | |
| 2024-05-01 05:27:49 -0500 | Rating Details | |
| 2024-05-01 05:24:03 -0500 | Rating Details | |
| 2024-05-01 04:48:52 -0500 | Rating Details | |
| 2024-05-01 00:47:10 -0500 | Rating Details | |
| 2024-04-30 22:31:55 -0500 | Rating Details | |
| 2024-04-30 22:13:07 -0500 | Rating Details | |
| 2024-04-30 21:29:01 -0500 | Rating Details | |
| 2024-04-30 20:40:05 -0500 | Rating Details | |
| 2024-04-30 20:34:31 -0500 | Rating Details | |
| 2024-04-30 19:40:18 -0500 | Rating Details | |
| 2024-04-30 19:36:45 -0500 | Rating Details | |
| 2024-04-30 19:32:57 -0500 | Rating Details | |
| 2024-04-30 19:26:47 -0500 | Rating Details | |
| 2024-05-03 09:53:58 -0500 | Rating Details | |
| 2024-05-03 09:20:17 -0500 | Rating Details | |
| 2024-05-03 09:18:53 -0500 | Rating Details | |
| 2024-05-03 05:41:32 -0500 | Rating Details | |
| 2024-05-03 05:30:35 -0500 | Rating Details | |
| 2024-05-03 03:46:57 -0500 | Rating Details | |
| 2024-05-01 21:41:32 -0500 | Rating Details | |
| 2024-05-05 19:34:55 -0500 | Rating Details | |
| 2024-05-03 10:11:36 -0500 | Rating Details | |
| 2024-05-03 10:09:50 -0500 | Rating Details | |
| 2024-05-03 08:42:50 -0500 | Rating Details | |
| 2024-05-03 08:27:21 -0500 | Rating Details | |
| 2024-05-03 05:07:32 -0500 | Rating Details | |
| 2024-05-03 04:43:00 -0500 | Rating Details | |
| 2024-05-03 04:24:11 -0500 | Rating Details | |
| 2024-05-08 06:55:38 -0500 | Rating Details | |
| 2024-05-03 11:14:21 -0500 | Rating Details | |
| 2024-05-03 10:06:11 -0500 | Rating Details | |
| 2024-05-03 07:13:47 -0500 | Rating Details | |
| 2024-05-03 06:28:41 -0500 | Rating Details | |
| 2024-05-03 05:37:20 -0500 | Rating Details | |
| 2024-05-03 05:23:36 -0500 | Rating Details | |
| 2024-05-03 03:19:31 -0500 | Rating Details | |
| 2024-05-01 14:56:20 -0500 | Rating Details | |
| 2024-05-01 06:04:16 -0500 | Rating Details | |
| 2024-05-01 05:29:24 -0500 | Rating Details | |
| 2024-05-01 05:02:11 -0500 | Rating Details | |
| 2024-05-01 04:50:47 -0500 | Rating Details | |
| 2024-04-30 23:54:33 -0500 | Rating Details | |
| 2024-04-30 23:24:39 -0500 | Rating Details | |
| 2024-04-30 23:12:39 -0500 | Rating Details | |
| 2024-04-30 21:26:18 -0500 | Rating Details | |
| 2024-04-30 21:02:11 -0500 | Rating Details | |
| 2024-04-30 21:01:04 -0500 | Rating Details | |
| 2024-04-30 21:00:46 -0500 | Rating Details | |
| 2024-04-30 20:20:38 -0500 | Rating Details | |
| 2024-04-30 19:55:45 -0500 | Rating Details | |
| 2024-04-30 19:37:46 -0500 | Rating Details | |
| 2024-04-30 19:08:38 -0500 | Rating Details | |
| 2024-05-03 01:20:40 -0500 | Rating Details | |
| 2024-05-03 06:55:49 -0500 | Rating Details | |
| 2024-05-01 08:42:52 -0500 | Rating Details | |
| 2024-05-03 02:02:49 -0500 | Rating Details | |
| 2024-05-01 21:09:11 -0500 | Rating Details | |
| 2024-05-01 07:09:32 -0500 | Rating Details | |
| 2024-04-30 21:15:31 -0500 | Rating Details |